Bursa Malaysia Stock Watch
TMCLIFE - OSK Research maintains Sell on TMC Life Sciences
kltrader
Publish date: Thu, 19 Aug 2010, 11:53 AM
kltrader
0 20,412
This blog provides consolidated Bursa Malaysia stock market research, analysis, news and blogs from various sources. You can search and find all the past analysis and coverage on stocks and news by searching within this site. While this blog re-publishes contents from other sites, it does not own the rights nor responsible for the accuracy of the contents. If you disagree to your content from being published here, please add a comment, and your article will be removed from this site.
Stock Name: TMCLIFE
Company Name: TMC LIFE SCIENCES BHD
Research House: OSK
KUALA LUMPUR: OSK Research is maintaining its Sell call on TMC Life Sciences and earnings forecast but revise higher its fair value (FV) to 30 sen based on about 2.0 times FY10 P/NTA.
It said on Thursday, Aug 19 that it was revising higher its FV because it did not dismiss the possibility of the currently buoyant stock market sentiment.
Underpinning its higher FV and expectations of future corporate actions from the new shareholder Peter Lim Eng Hock, OSK Research said these factors would help to sustain TMC's share price at around the 52 sen transacted price.
Therefore TMC is unlikely to retrace much lower towards its previous 21 sen price target, it said.
'We had earlier speculated that the new shareholder could be a reputable industry player which could turn around the medical centre faster. However, we are uncertain of the expertise of Lim in the medical industry,' it said.
Company Name: TMC LIFE SCIENCES BHD
Research House: OSK
KUALA LUMPUR: OSK Research is maintaining its Sell call on TMC Life Sciences and earnings forecast but revise higher its fair value (FV) to 30 sen based on about 2.0 times FY10 P/NTA.
It said on Thursday, Aug 19 that it was revising higher its FV because it did not dismiss the possibility of the currently buoyant stock market sentiment.
Underpinning its higher FV and expectations of future corporate actions from the new shareholder Peter Lim Eng Hock, OSK Research said these factors would help to sustain TMC's share price at around the 52 sen transacted price.
Therefore TMC is unlikely to retrace much lower towards its previous 21 sen price target, it said.
'We had earlier speculated that the new shareholder could be a reputable industry player which could turn around the medical centre faster. However, we are uncertain of the expertise of Lim in the medical industry,' it said.
More articles on Bursa Malaysia Stock Watch
Tambun Indah - The 2nd Penang Bridge To Narrow Property Price Gap
Created by kltrader | Oct 11, 2012
Plantation ' Share Prices Not Reflecting CPO Price Movement ' Is A Correction Coming? (Neutral)
Created by kltrader | Oct 11, 2012
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Latest Videos
Apps
Top Articles
1
2
Good Articles to Share
3
4
MQ Market Updates
5
M+ Online Research Articles
6
THE INVESTMENT APPROACH OF CALVIN TAN
7
BFM Podcast
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
MQ Trading Signals
Stock
Time
Signal
Duration
Stock
Time
Signal
Duration
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
